iopentol has been researched along with diatrizoic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, TW; Rubinstein, R | 1 |
| Krause, W; Niehues, D | 1 |
| Brekke, O; Lanning, P | 1 |
| Bjartveit, K; Brock, A; Kruse, A; Nowakowska-Duawa, E; Rodenberg, J | 1 |
| Eide, H; Friedrich, JM; Merkle, E; Skinningsrud, K; Welter, C | 1 |
| Jakobsen, JA; Klaveness, AJ; Valentine, A | 1 |
| Christopoulos, S; Kokkas, B; Mironidou, M; Ximitidou, O | 1 |
| Becker, EW; Brockow, K; Ring, J; Worret, WI | 1 |
4 trial(s) available for iopentol and diatrizoic acid
| Article | Year |
|---|---|
Iopentol (Imagopaque 300) compared with iohexol (Omnipaque 300) and diatrizoate (Urografin 292) in pediatric urography. A clinical trial assessing adverse events and diagnostic information.
Topics: Child; Child, Preschool; Contrast Media; Diatrizoate; Double-Blind Method; Female; Humans; Infant; Iohexol; Male; Safety; Triiodobenzoic Acids; Urography | 1997 |
Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
Topics: Amylases; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Diatrizoate; Double-Blind Method; Female; Humans; Isoenzymes; Male; Middle Aged; Pancreatitis; Safety; Triiodobenzoic Acids | 1997 |
Oral administration of iopentol (Imagopaque 300 mg I/ml) compared with amidotrizoate (Peritrast 300 mg I/ml), both diluted to 2% (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CT. A clinical trial assessing patient toleranc
Topics: Administration, Oral; Contrast Media; Diatrizoate; Digestive System; Double-Blind Method; Female; Humans; Male; Middle Aged; Safety; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1997 |
Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT. A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements).
Topics: Brain; Contrast Media; Diatrizoate; Double-Blind Method; Female; Humans; Male; Middle Aged; Safety; Time Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1997 |
4 other study(ies) available for iopentol and diatrizoic acid
| Article | Year |
|---|---|
Concentration-dependent myocardial effects of citrate in a nonionic contrast medium.
Topics: Animals; Cardiac Catheterization; Citrates; Citric Acid; Contrast Media; Diatrizoate; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Injections, Intra-Arterial; Ioxaglic Acid; Myocardial Contraction; Triiodobenzoic Acids | 1991 |
Biochemical characterization of x-ray contrast media.
Topics: 1-Butanol; Animals; Biochemical Phenomena; Biochemistry; Butanols; Chemical Precipitation; Complement Activation; Contrast Media; Diatrizoate; Dogs; Drug Incompatibility; Enzyme Inhibitors; Erythrocytes; Female; Hemolysis; Histamine Release; Iodipamide; Iopamidol; Ioxaglic Acid; Male; Mast Cells; Matrix Metalloproteinase Inhibitors; Muramidase; Photometry; Protein Binding; Rats; Sheep; Spectrophotometry; Streptokinase; Tissue Plasminogen Activator; Triiodobenzoic Acids; Urokinase-Type Plasminogen Activator; Water | 1996 |
The effect of some iodinated contrast media on human plasma butyrylcholinesterase activity.
Topics: Aged; Butyrylcholinesterase; Colorimetry; Contrast Media; Diatrizoate; Female; Humans; Iohexol; Male; Middle Aged; Triiodobenzoic Acids; Urography | 1998 |
Late skin test reactions to radiocontrast medium.
Topics: Aged; Allergens; Contrast Media; Diatrizoate; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Melanoma; Pruritus; Skin Tests; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1999 |